tiprankstipranks
Trending News
More News >
UnitedHealth (DE:UNH)
XETRA:UNH
Germany Market

UnitedHealth (UNH) Stock Forecast & Price Target

Compare
70 Followers
See the Price Targets and Ratings of:

UNH Analyst Ratings

Strong Buy
19Ratings
Strong Buy
16 Buy
3 Hold
0 Sell
Based on 19 analysts giving stock ratings to
UnitedHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

€312.74
▲(29.47% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is €312.74 with a high forecast of €373.42 and a low forecast of €263.94. The average price target represents a 29.47% change from the last price of €241.55.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"206":"€206","359":"€359","512":"€512","282.5":"€282.5","435.5":"€435.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":373.419332,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€373.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":312.73869055,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€312.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":263.9395733,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€263.94</span>\n  </div></div>","useHTML":true}}],"tickPositions":[206,282.5,359,435.5,512],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,245.2,255.06302553846152,264.92605107692305,274.7890766153846,284.65210215384616,294.5151276923077,304.3781532307692,314.24117876923077,324.10420430769227,333.9672298461538,343.8302553846154,353.69328092307694,363.55630646153844,{"y":373.419332,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,245.2,250.39528388846153,255.59056777692308,260.7858516653846,265.9811355538462,271.1764194423077,276.3717033307692,281.5669872192308,286.7622711076923,291.9575549961538,297.1528388846154,302.3481227730769,307.5434066615385,{"y":312.73869055,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,245.2,246.64150563846152,248.08301127692306,249.5245169153846,250.96602255384616,252.4075281923077,253.84903383076923,255.29053946923077,256.73204510769233,258.17355074615386,259.6150563846154,261.05656202307694,262.49806766153847,{"y":263.9395733,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":511.293,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":443.989,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":477.458,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":353.939,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.977,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.217,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.359,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":262.197,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":295.461,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 70,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":293.971,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.277,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€373.42Average Price Target€312.74Lowest Price Target€263.94
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on DE:UNH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Analysts Offer Insights on Healthcare Companies: Butterfly Network (NYSE: BFLY), UnitedHealth (NYSE: UNH) and Travere Therapeutics (NASDAQ: TVTX)
Mizuho Securities Analyst forecast on DE:UNH
Mizuho Securities
Mizuho Securities
€363.6€295.95
Buy
22.52%
Upside
Reiterated
02/05/26
UnitedHealth price target lowered to $350 from $430 at MizuhoUnitedHealth price target lowered to $350 from $430 at Mizuho
Piper Sandler Analyst forecast on DE:UNH
Piper Sandler
Piper Sandler
€334.85€329.77
Buy
36.52%
Upside
Reiterated
02/03/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)
Truist Financial Analyst forecast on DE:UNH
Truist Financial
Truist Financial
€346.68€312.86
Buy
29.52%
Upside
Reiterated
02/02/26
Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)
J.P. Morgan Analyst forecast on DE:UNH
Bram Kaplan
J.P. Morgan
Not Ranked
J.P. Morgan
€359.37€328.93
Buy
36.17%
Upside
Reiterated
02/02/26
UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan
Wells Fargo Analyst forecast on DE:UNH
Wells Fargo
Wells Fargo
€338.23€312.86
Buy
29.52%
Upside
Reiterated
01/30/26
UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo
Barclays
€330.62€276.5
Buy
14.47%
Upside
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)
Bernstein Analyst forecast on DE:UNH
Bernstein
Bernstein
€375.43€342.46
Buy
41.77%
Upside
Reiterated
01/29/26
UnitedHealth (UNH) Gets a Buy from Bernstein
TD Cowen
€285.8€262.97
Hold
8.87%
Upside
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)
Morgan Stanley Analyst forecast on DE:UNH
Morgan Stanley
Morgan Stanley
€345.84€317.09
Buy
31.27%
Upside
Reiterated
01/28/26
UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds
Oppenheimer
€350.91€325.54
Buy
34.77%
Upside
Reiterated
01/28/26
UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer
UBS
€363.6€346.68
Buy
43.52%
Upside
Reiterated
01/28/26
UnitedHealth price target lowered to $410 from $430 at UBSUnitedHealth price target lowered to $410 from $430 at UBS
Jefferies Analyst forecast on DE:UNH
Jefferies
Jefferies
€287.49
Buy
19.02%
Upside
Reiterated
01/28/26
Jefferies Sticks to Their Buy Rating for UnitedHealth (UNH)
Cantor Fitzgerald Analyst forecast on DE:UNH
Cantor Fitzgerald
Cantor Fitzgerald
€372.05
Buy
54.03%
Upside
Reiterated
01/28/26
Cantor Fitzgerald Keeps Their Buy Rating on UnitedHealth (UNH)
KeyBanc
€338.23
Buy
40.02%
Upside
Reiterated
01/28/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank  Analyst forecast on DE:UNH
Deutsche Bank
Deutsche Bank
Hold
Reiterated
02/20/26
Analysts Offer Insights on Healthcare Companies: Butterfly Network (NYSE: BFLY), UnitedHealth (NYSE: UNH) and Travere Therapeutics (NASDAQ: TVTX)
Mizuho Securities Analyst forecast on DE:UNH
Mizuho Securities
Mizuho Securities
€363.6€295.95
Buy
22.52%
Upside
Reiterated
02/05/26
UnitedHealth price target lowered to $350 from $430 at MizuhoUnitedHealth price target lowered to $350 from $430 at Mizuho
Piper Sandler Analyst forecast on DE:UNH
Piper Sandler
Piper Sandler
€334.85€329.77
Buy
36.52%
Upside
Reiterated
02/03/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)
Truist Financial Analyst forecast on DE:UNH
Truist Financial
Truist Financial
€346.68€312.86
Buy
29.52%
Upside
Reiterated
02/02/26
Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)
J.P. Morgan Analyst forecast on DE:UNH
Bram Kaplan
J.P. Morgan
Not Ranked
J.P. Morgan
€359.37€328.93
Buy
36.17%
Upside
Reiterated
02/02/26
UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan
Wells Fargo Analyst forecast on DE:UNH
Wells Fargo
Wells Fargo
€338.23€312.86
Buy
29.52%
Upside
Reiterated
01/30/26
UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo
Barclays
€330.62€276.5
Buy
14.47%
Upside
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)
Bernstein Analyst forecast on DE:UNH
Bernstein
Bernstein
€375.43€342.46
Buy
41.77%
Upside
Reiterated
01/29/26
UnitedHealth (UNH) Gets a Buy from Bernstein
TD Cowen
€285.8€262.97
Hold
8.87%
Upside
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)
Morgan Stanley Analyst forecast on DE:UNH
Morgan Stanley
Morgan Stanley
€345.84€317.09
Buy
31.27%
Upside
Reiterated
01/28/26
UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds
Oppenheimer
€350.91€325.54
Buy
34.77%
Upside
Reiterated
01/28/26
UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer
UBS
€363.6€346.68
Buy
43.52%
Upside
Reiterated
01/28/26
UnitedHealth price target lowered to $410 from $430 at UBSUnitedHealth price target lowered to $410 from $430 at UBS
Jefferies Analyst forecast on DE:UNH
Jefferies
Jefferies
€287.49
Buy
19.02%
Upside
Reiterated
01/28/26
Jefferies Sticks to Their Buy Rating for UnitedHealth (UNH)
Cantor Fitzgerald Analyst forecast on DE:UNH
Cantor Fitzgerald
Cantor Fitzgerald
€372.05
Buy
54.03%
Upside
Reiterated
01/28/26
Cantor Fitzgerald Keeps Their Buy Rating on UnitedHealth (UNH)
KeyBanc
€338.23
Buy
40.02%
Upside
Reiterated
01/28/26
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), HCA Healthcare (NYSE: HCA) and Cardiff Oncology (NASDAQ: CRDF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

3 Months
xxx
Success Rate
29/45 ratings generated profit
64%
Average Return
+5.34%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.44% of your transactions generating a profit, with an average return of +5.34% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
35/43 ratings generated profit
81%
Average Return
+20.31%
reiterated a buy rating 4 months ago
Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.40% of your transactions generating a profit, with an average return of +20.31% per trade.
2 Years
xxx
Success Rate
37/45 ratings generated profit
82%
Average Return
+39.86%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.22% of your transactions generating a profit, with an average return of +39.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
70
58
44
37
37
Hold
23
25
24
23
18
Sell
2
1
1
0
0
Strong Sell
0
0
0
0
0
total
95
84
69
60
55
In the current month, UNH has received 37 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. UNH average Analyst price target in the past 3 months is 312.74.
Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is €5.74 with a range of €4.24 to €6.58. The previous quarter’s EPS was €1.79. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.
Next quarter’s earnings estimate for UNH is €5.74 with a range of €4.24 to €6.58. The previous quarter’s EPS was €1.79. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is €92.89B with a range of €90.52B to €96.58B. The previous quarter’s sales results were €95.92B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.
Next quarter’s sales forecast for UNH is €92.89B with a range of €90.52B to €96.58B. The previous quarter’s sales results were €95.92B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Stock Forecast FAQ

What is DE:UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is 312.74.
    What is DE:UNH’s upside potential, based on the analysts’ average price target?
    UnitedHealth has 29.47% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UnitedHealth a Buy, Sell or Hold?
          UnitedHealth has a consensus rating of Strong Buy, which is based on 16 buy ratings, 3 hold ratings and 0 sell ratings.
            What is UnitedHealth’s share price target?
            The average share price target for UnitedHealth is 312.74. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €373.42 ,and the lowest forecast is €263.94. The average share price target represents 29.47% Increase from the current price of €241.55.
              What do analysts say about UnitedHealth?
              UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of UnitedHealth?
                To buy shares of DE:UNH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.